Anti-MAG

Anti-MAG (also called GSK249320). This study has been completed.

Countries: USA, Germany and Australia
 
Healthy subjects

Company: GlaxoSmithKline

A 1 dose intravenous therapy of GSK249320 in healty subjects to assess safety. Spinal cord injured patients will be enrolled on later stages.

Status: Phase I

For more information click here.